Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-01-05

Clinical Trial Update: Safety of Ertapenem in Beta-lactam Allergic Patients. [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update assessing the safety of ertapenem in patients with beta-lactam allergy, focusing on IgE-mediated hypersensitivity and allergic r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ERTAPENEM (ertapenem)
  • Invanz (ertapenem)

Snippet

Sponsor: Catholic University of the Sacred Heart | Conditions: IgE-Mediated Hypersensitivity, Allergy | Phase 4 | Status: UNKNOWN